diseases

Findings show significant links between airport-based first responders’ perceptions of COVID-19 and their experiences with it.

The NIH grant will fund the development, optimization and testing of three promising options against the deadly disease.

Texas A&M researchers use nanotechnology to recharge the "powerhouse of the cell" in fight against disease and aging.

Vessel-chip technology may offer more personalized pharmaceutical drug testing, leading to our improved ability to combat disease.

Study findings raise the stakes for public health efforts to improve attitudes about vaccination rates across the board.

The wide-ranging mosquito airborne disease could affect pets, livestock and humans.

New research sheds light on how a genetic mutation affecting mitochondria influences chronic inflammatory disorders and immune responses.

Biologist Joseph Sorg is leading a team to analyze C. difficile, which kills at least 29,000 people a year.

$1.4 million in funding from the National Institutes of General Medical Sciences will help Texas A&M researchers shed new light on the disorder.

Adela Chavez's research focuses on preventing the negative health and economic impacts of tick-borne diseases.